In this episode of Talking Trusts, we speak to Ailsa Craig & Marek Poszepczynski, managers of International Biotechnology Trust (IBT), about recent performance, portfolio allocation and the most exciting opportunities in the biotech sector.
00:00 Introduction
00:24 Key drivers of outperformance
01:46 Thoughts on recovery
03:22 Managing political appointments
06:36 Overview of current allocations
09:33 Weighting to SMIDs
10:48 Exposure to GLP-1s
13:39 Evolution of portfolio
16:12 Thoughts on M&A
18:02 Upcoming patent expiries
19:25 Availability of capital raising
20:36 Impact of AI on clinical trials
22:27 Further information
22:38 Risk warning
Please note this video was filmed on 1 July 2025.
